DDIT3 and pancreatic neoplasm: Thus, the major original result from this research is that in the Gemcitabine-resistant pancreatic cancer cell lines tested, the LC3 B-dependent GK733-induced LC3 II formation is an initial event upstream of both AMPK and PERK/CHOP signaling pathways.